9-12 : 0.2 mg weekly
Severe Obesity and Established Cardiovascular Disease TRIUMPH-3 (NCT05882045) evaluated 1,949 adults with Class II or Class III obesity (body mass index of at least 35 kg/m) and established cardiovascular disease, with or without type 2 diabetes
These peptides are studied for their roles in cellular signaling related to tissue repair, regeneration pathways, and collagen-related processes
When to Discuss Alternatives With a Clinician Alternatives should be discussed when the goal involves a medical condition such as diabetic ulcers, hair loss, chronic wounds, inflammatory disease, scarring, or post-procedure recovery
In case further glycemic control is still needed, the dose can be augmented to 1.8 mg daily
RESEARCH USE ONLY Not for human or veterinary use BATCH VERIFIED Research Use Only This product is strictly for in vitro research and laboratory use only